PATENT CLAIM ANALYSIS

Application Number: 16255759
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "401000"]

Abstract:
A cosmetic composition includes water in an amount of from 20% to 70% by weight of the total composition; saturated fats in an amount of 6% to 15% by weight of the total composition; and an emulsifier. The cosmetic composition may be free from preservatives.

Claim (Index 60):
A cosmetic composition comprising\n (a) a colloidal dispersion of a clay; (b) water in an amount of 10 to 30% by weight of the total composition; and (c) humectant in an amount of 25 to 60% by weight of the total composition,\n wherein the weight of the clay is greater than the weight of the water, \n wherein the humectant comprises glycerine, and \n wherein the cosmetic composition contains no preservatives or preservatives selected from: Benzoic acid no greater than 0.062% wt; Sodium benzoate no greater than 0.062% wt; Salts of benzoic acid excluding sodium benzoate no greater than 0.003% w/v; Propionic acid and salts thereof no greater than 0.0032% w/v; Salicylic acid and salts thereof no greater than 1% w/v; Hexa-2,4-dienoic acid and salts thereof no greater than 0.4% w/v; Formaldehyde no greater than 0.01% w/v; Paraformaldehyde no greater than 0.01% w/v; Biphenyl-2-ol and salts thereof no greater than 1\u00d710 \u22125 % w/v; Pyrithione zinc no greater than 1.6\u00d710 \u22124 % w/v; Inorganic sulphites no greater than 1.6\u00d710 \u22125 % w/v; Inorganic sulphites no greater than 1.6\u00d710 \u22125 % w/v; Hydrogen sulphites no greater than 1.6\u00d710 \u22125 % w/v; Chlorobutanol no greater than 0.25% w/v; 4-Hydroxybenzoic acid and salts thereof and esters thereof no greater than 1.2\u00d710 \u22122 % w/v; 3-Acetyl-6-methylpyran-2,4(3H)-dione and salts thereof no greater than 1\u00d710 \u22123 % w/v; Formic acid no greater than 6\u00d710 \u22123 % w/v; Sodium formate no greater than 6\u00d710 \u22123 % w/v; Methenamine 3-chloroallylochloride no greater than 5\u00d710 \u22123 % w/v; 1-(4-Chlorophenoxy)-1- \n (imidazole-1-yl)-3 ,3 -dimethylbutan-2-one no greater than 6.3\u00d710 \u22125 % w/v; 1,3-Bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione no greater than 6.3\u00d710 \u22125 % w/v; Benzyl alcohol no greater than 0.0625% w/v; 1-Hydroxy-4-methyl-6-(2,4,4-trimethylpentyl) 2-pyrindon no greater than 1.6\u00d710 \u22125 % w/v; Monoethanolamine salt of 1-Hydroxy-4-methyl-6-(2,4,4-trimethylpentyl) 2-pyrindon no greater than 1.6\u00d710 \u22125 % w/v; 2,2\u2032-methylenebis(6-bromo-4-chlorophenol) no greater than 2 \u00d710 \u22123 % w/v; 4-Isopropyl-m-cresol no greater than 0.1% w/v; 5-Chloro-2-methyl-isothiazol-3(2H)-one no greater than 1.6\u00d710 \u22123 % w/v; 2-methyl-isothiazol-3(2H)-one no greater than 1.6\u00d710 \u22123 % w/v; 2-Benzyl-4-chlorophenol no greater than 0.1% w/v; 2-Chloroacetamide no greater than 6.25\u00d710 \u22123 % w/v; N,N\u2033-bis(chlorophenyl)-3,12-diamino-2,4,11,13-tetraazatetradecadiamidine no greater than 5\u00d710 \u22124 % w/v; digluconate of N,N\u2033-bis (chlorophenyl)-3,12-diamino-2,4,11,13-tetraazatetradecadiamidine no greater than 5\u00d710 \u22124 % w/v; diacetate of N,N\u2033-bis(chlorophenyl)-3,12-diamino-2,4,11,13-tetraazatetradecadiamidine no greater than 5\u00d710 \u22124 % w/v; dihydrochloride of N,N\u2033-bis (chlorophenyl)-3,12-diamino-2,4,11,13-tetraazatetradecadiamidine no greater than 5\u00d710 \u22124 % w/v; 1-Phenoxypropanol-2-ol no greater than 0.1% w/v; Alkyl(C 12-22 )trimethyl ammonium bromide no greater than 6.1\u00d710 \u22123 % w/v; Alkyl(C 12-22 )trimethyl ammonium chloride no greater than 6.1\u00d710 \u22123 % w/v; 4,4-Dimethyl-1,3-oxazolidine no greater than 3\u00d710\u2032 % w/v; N-(hydroxymethyl)-N-(dihydroxymethyl-1,3-dioxo-2,5-imidazolidinyl-4)-N\u2032(hydroxymethyl) urea no greater than 3\u00d710 \u22125 % w/v; Benzenecarboximidamide, 4,4\u2032-(1,6-hexanediylbis (oxy))bis- no greater than 0.116% w/v; Salts of Benzenecarboximidamide, 4,4\u2032-(1,6-hexanediylbis(oxy))bis- no greater than 0.116% w/v; Glutaraldehyde (pentane-1,5-dial) no greater than 5\u00d710 \u22124 % w/v; 5-Ethyl-3,7-dioxa-1-azabicyclo [3.3.0] octane no greater than 1.5\u00d710 \u22124 % w/v; 3-(p-Chlorophenoxy)-propane-1,2 diol no greater than 1.25% w/v; Sodium hydroxymethylamino acetate no greater than 2\u00d710 \u22125 % w/v; Silver chloride no greater than 3.12\u00d710 \u22123 % w/v; Benzalkonium chloride no greater than 4\u00d710 \u22123 % w/v; Benzalkonium bromide no greater than 4\u00d710 \u22123 % w/v; Benzalkonium saccharinate no greater than 4\u00d710 \u22123 % w/v; Phenylmethoxy methanol no greater than 3\u00d710 \u22125 % w/v; 3-Iodo-2-propynylbutylcarbamate no greater than 6.25\u00d710 \u22123 % w/v.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 99.0
- Lexical Diversity: 1.70968
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14775125', '11912839', '13003404', '14653305', '15280459']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7006380754392115
- 35 USC 102 Novelty (BERT): 0.4965408839132392
- Combined Prediction Score: 0.6802283562866143
- Mean Citation Score: 175.049602
- Max Citation Score: 182.073
- Similarity Product: 111.21387243264914

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test